January 15, 2021
1 min watch
Save
VIDEO: CAR-T techniques could be applied to COVID-19 management
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
Neetu Gupta, PhD, associate professor at Cleveland Clinic Foundation, discussed data comparing cytokine release syndrome in CAR T-therapy to COVID-19 at the ASH Annual Meeting and Exposition.
“This study suggests that the lessons that you learn from CAR-T associated cytokine release syndrome, which is what we are performing here, may actually be applied toward management of cytokine release syndrome resulting from COVID-19,” Gupta told Healio.
Published by:
Sources/Disclosures
Collapse
Source:
Hong, R et al. Abstract 704. Presented at: ASH Annual Meeting and Exposition (virtual meeting); Dec. 5-8, 2020.
Disclosures:
Gupta has no relevant financial disclosures to report.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.